Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester

Journal of Photochemistry and Photobiology B: Biology

Volumn 67, Issue 1, 2002, Pages 11-17

  Juzenas, Petras ^a,b,c   Sharfaei, Soraya ^a   Moan, Johan ^b   Bissonnette, Robert ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Anticarcinogenesis; Fluorescence kinetics; Photobleaching; Photodynamic therapy; UV photocarcinogenesis

Indexed keywords

AMINO ACID DERIVATIVE; AMINOLEVULINIC ACID METHYL ESTER; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG; AMINOLEVULINIC ACID; DELTA AMINOLEVULINIC ACID METHYL ESTER; DELTA-AMINOLEVULINIC ACID METHYL ESTER; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEACHING; CHEMICAL REACTION KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREAM; FEMALE; FLUORESCENCE SPECTROSCOPY; LIGHT EXPOSURE; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SKIN TUMOR; TUMOR MODEL; ULTRAVIOLET RADIATION; ANIMAL; DRUG EFFECT; FLUORESCENCE; HAIRLESS MOUSE; KINETICS; METABOLISM; RADIATION EXPOSURE; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMAL; FEMALE; FLUORESCENCE; KINETICS; MICE; MICE, INBRED HRS; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; ULTRAVIOLET RAYS; ANIMALS;

EID: 0036114299     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(02)00269-5     Document Type: Article

References (44)

1. Photosensitizers: Therapy and detection of malignant tumours
2. Photodynamic therapy
3. Laser-based spectroscopic methods in tissue characterization
4. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo
5. Photodynamic therapy in dermatology
6. Topical photodynamic therapy for localized scleroderma
7. Photodynamic therapy in dermatology
8. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylenediaminetetraacetic acid: A comparison of two light sources
9. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma
10. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
11. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo
12. Preferential relative porphyrin enrichment in solar keratoses upon topical application of aminolevulinic acid methylester
13. Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo
14. A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?
15. Porphyrin metabolism in some malignant diseases
16. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-amino-levulinic acid (ALA)
17. On the basis for tumour selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX
18. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy
19. Photodynamic therapy using intravenous delta-amino-laevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats
20. Photosensitization of murine tumour, vasculature and skin by 5-aminolevulinic acid-induced porphyrin
21. 5-Aminolevulinic acid and its derivatives: Physical chemical properties and protoporphyrin IX formation in cultured cells
22. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture
23. Derivatives of 5-aminolevulinic acid for photodynamic therapy: Enzymatic conversion into protoporphyrin
24. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo
25. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice
26. Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin IX
27. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma
28. Light and drug distribution with topically administered photosensitizers
29. Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester
30. Development of skin tumours in hairless mice after discontinuation of ultraviolet irradiation
31. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of light dose and irradiance and the resulting biological effect
32. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin
33. Photoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumours in hairless mouse skin
34. Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon
35. Photooxidation and singlet oxygen sensitization by protoporphyrin IX and its photooxidation products
36. Phototransformations of sensitizers. 2. Photoproducts formed in aqueous solutions of porphyrins
37. Protoprotoporphyrine und ihre Umwandlung in Spirographis-sowie Isospirographis-porphyrin
38. On the role of protoporphyrin IX photoproducts in photodynamic therapy
39. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy
40. Benefits and adverse effects from the combination of drugs and light
41. Kinetics of photobleaching of protoporphyrin IX in the skin of nude mice exposed to different fluence rates of red light
42. Oxygen consumption and diffusion effects in photodynamic therapy
43. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry
44. Fluence rate effects in photodynamic therapy of multicell tumour spheroids